French Health Minister Olivier Véran has hailed the country’s Covid-19 health pass as a success, adding that similar initiatives are now being introduced in “dozens” of other countries around the world. Speaking to France 5, Mr Véran said other countries were now considering similar initiatives having seen the impact made in France. The health pass obliges people to show proof of full vaccination, a recent negative test or recent recovery from Covid-19 to be able to enter restaurants, bars and a range of other public spaces. Since the pass was announced by President Emmanuel Macron on July 12, some 12 million people (equivalent to 18% of France’s population) have been vaccinated, according to Prime Minister Jean Castex. Back in March, only 3% of the French population had been fully vaccinated against Covid-19, according to Le Monde. But this figure has now risen to 67%, highlighting how more and more people are receiving a Covid vaccine. Interestingly, take-up among the young has been particularly high considering vaccination was delayed for this group. Meanwhile, Covid health passes will no longer be required for entry into all but 64 French shopping centres this week. From Wednesday the health pass obligation will no longer apply to centres of more than 20,000 square metres in departments where the infection rate has dropped below 200 per 100,000 residents, and where cases have been falling for a week or more, Economy Minister Bruno Le Maire announced yesterday (September 6). *Image by Please Don't sell My Artwork AS IS from Pixabay
For stroke patients, receiving treatment as soon as possible is vital. The shorter time between the stroke and treatment, the less chance there is of serious damage to the patient’s brain. That’s why fast diagnosis of a stroke is so important for the patient’s overall prognosis. But vascular neurologists, the clinicians most called upon to check stroke patients, are often in short supply and high demand. As a result, they cannot always see every suspected stroke patient as quickly as perhaps liked. The answer has been to utilise telemedicine and this is something neurologists have been doing for more than three decades. By taking advantage of audio-visual platforms, neurologists can assess suspected stroke patients quickly. If the patient is displaying signs of a stroke, they can be given life-saving treatment, consisting of administering tissue plasminogen activator (tPA), a clot-dissolving drug first developed for treating heart attacks, which was then fine-tuned for strokes in the early 1990s. The success of tPA, however, lies in administering it as quickly as possible, to counter the effect of blood loss to the brain. A 2016 study highlights the impact of telehealth for stroke patients. According to Kaiser Permanente’s study, involving more than 2,500 patients treated for stroke symptoms between 2013 and 2015 in its 14-hospital network in southern California, a 75% increase was witnessed in the timely use of tPA after a telehealth consult. Patients receiving a telehealth consult were given a diagnostic imaging test 12 minutes sooner than those who didn’t, and tPA was administered 11 minutes sooner. Overall, the door-to-needle time was reduced to less than an hour. *Image by Gerd Altmann from Pixabay
Before the COVID-19 pandemic, ear, nose and throat (ENT) specialist Dr Clair Vandersteen might have treated around 10 patients a year for anosmia, the inability to smell. But fast-forward to today and Dr Vandersteen has seen demand for his services increase significantly. Now, the majority of his patients are those recovering from COVID-19, up to 15 a week, in fact, at the doctor’s clinic in the Centre Hospitalier Universitaire de Nice. Loss of smell is a symptom in eight out of 10 COVID-19 cases and can the effects can sometimes linger for months after the patient has recovered from the disease. “We have seen a very large increase in patients since this time a year ago,” Dr Vandersteen said. The ENT specialist says studies show that 20% of people who lost their sense of smell still had not regained it and it’s younger individuals that appear to be worst affected. “The patients we see suffering from a loss of smell are relatively young. It is predominantly a problem that affects people in their 30s and 40s.” While for some people it might seem little more than an inconvenience, Dr Vandersteen warns the condition can make patients anxious and depressed. “The loss of smell can lead to psychological problems – 30% of people who have lost their sense of smell due to Covid are suffering from some kind of psychological damage. We love eating, especially here in France, so when chocolate tastes like cigarettes, for example, it can lead to people feeling unhappy or anxious. “If you can’t enjoy the smell of your newborn baby, or the smell of your home, it can be unsettling. It can also be dangerous – if you can’t smell gas or smoke, for example.” Dr Vandersteen’s team has come up with a three-pronged approach to help. First, patients see Dr Vandersteen, who determines their level of smell loss. Then, they are seen by Auriane Gros, a doctor of neuroscience and a speech pathologist, who helps re-educate the brain to recover the perception of smells. The final step is therapy with child psychiatrist Louise-Emilie Dumas, who runs group workshops around odours. “The team has had positive results,” Dr Vandersteen says. *Image courtesy of Dr Clair Vandersteen
The southern French city of Nice has been added to the UNESCO World Heritage Committee’s list of world heritage sites. UNESCO announced its decision in a tweet, calling Nice -- famous for its mild climate -- the "Winter resort town of the Riviera". Nice joins more than 40 other world heritage sites in France, which include the banks of the river Seine in Paris, the Amiens cathedral, the Mont Saint Michel and stretches of the Loire Valley. "The history of Nice, which is at the same time deeply rooted and open, Mediterranean and Alpine, European and cosmopolitan, has produced an architecture and a landscape that are unique, a model for many other cities in the world," Nice's mayor, Christian Estrosi, said in reaction to the announcement. With close to one million inhabitants, greater Nice is the second-biggest city on the French Mediterranean coast after Marseille, and the fifth-biggest in France. Nice is a tourist hotspot, attracting several million visitors per year, and its airport is one of France’s busiest. The World Heritage Committee added a total of 13 cultural sites to UNESCO’s World Heritage List and one extension to an existing cultural site in Mexico. For more information about the 13 new world heritage sites, visit the UNESCO website here: https://en.unesco.org/news/cultural-sites-africa-arab-region-asia-europe-and-latin-america-inscribed-unescos-world *Image of Nice by Prosag-Media from Pixabay
France’s parliament approved a bill early on Monday requiring people to have a health pass to access restaurants, bars, trains and planes from the beginning of August. At present, all venues accommodating more than 50 people already require proof of vaccination or proof of a recent negative COVID-19 test. Museums, cinemas, swimming pools and other venues are all included under this law. As well as the health pass requirement for all restaurants and domestic travel, the French parliament has also approved mandatory vaccines for all health workers. The law requires all healthcare sector workers to start getting vaccinated by Sept. 15 or risk suspension. President Emmanuel Macron and his government say both steps are needed to protect vulnerable populations and hospitals as infections rebound, as well as avoid new lockdowns. The bill was unveiled just six days ago. Lawmakers worked through the night and the weekend to reach a compromise, which was approved by the Senate on Sunday night and by the National Assembly after midnight. To get the health pass, people in France must have proof they are fully vaccinated, recently tested negative for COVID-19 or recently recovered from the virus. Both paper and digital documents will be accepted.
Bastille Day is France’s national day and it is celebrated every year on July 14. But how did it get its name and why is it celebrated? One of the most important national holidays for people in France, Bastille Day is celebrated in remembrance of the storming of Paris’ Bastille Prison in 1789. It was on this day when revolutionists and mutinous troops stormed and captured the military fortress and prison. The event was significant as the Bastille had become a symbol of the French king, Louis XVI’s, harsh rule and tyranny. Its fall sparked the beginning of the French Revolution, which would last for a decade and see both King Louis and his wife, Marie Antoinette, executed by guillotine in 1793. The end of the French Revolution led to the formation of the French Consulate, the top-level government of France until Napoleon declared himself emperor in 1804. Bastille Day 2021 Yesterday, in spite of the COVID-19 pandemic, people all across France recognised Bastille Day. In Paris, French President Emmanuel Macron led the national day parade, which started at the Arc de Triomphe monument and ended with a ceremony on the Concorde square. Thousands of military and public security personnel paraded by foot, on vehicles and aboard jets over Paris' Champs Elysees Avenue yesterday. You can see some coverage of the military parade in this video: https://youtu.be/hgeLhCkFBwI *Image: “Taking of the Bastille” by Rama, Wikimedia Commons, Cc-by-sa-2.0-fr
France’s healthcare system is to benefit from €7bn worth of investment, which is designed to drive innovation in the sector. Speaking at the end of June, French President Emmanuel Macron announced that public funding would be made available in the wake of the COVID-19 pandemic in the country. Part of France’s Health Innovation Plan 2030, €2bn will be invested by the state-owned Banque Publique d'Investissement (BPI) in start-ups and small and medium-sized companies (SMEs) in the healthcare industry. France will also invest €2bn in research for emerging and infectious diseases, biotherapies and digital health. Following the COVID-19 pandemic, the plan will allocate almost €750 million for emerging infectious diseases and CBRN (nuclear, radiological, biological and chemical) threats. Another €800m will be dedicated to biotherapies and the bioproduction of innovative therapies that represent 50% of the clinical trials currently underway. These technologies enable the development of so-called personalised medicine by providing therapeutic solutions in oncology, immunology, virology and for rare diseases, for example. President Macron wants to make France the leading European country in healthcare innovation by 2030. He has committed to lift administrative hurdles to speed up organisational changes in the healthcare system. *Image by Parentingupstream from Pixabay
Hospitals in France are using virtual reality (VR) glasses to help patients relax and reduce their stress and pain during operations. Rouen and Strasbourg hospitals have both embraced the VR technology, which was launched last year by French start-up HypnoVR. The glasses can be worn by patients before, during and after surgery, helping them relax more, which can result in local anaesthesia being used instead of general during their procedure. The glasses can also help patients better manage post-surgery pain. They are said to be particularly effective for chemotherapy patients. Patients can choose from a range of virtual scenes, including a tropical beach, walking in the woods and even a journey into space. A calming voice accompanies the visuals and there are breathing exercises and a choice of music, too. While patients still have to receive anaesthesia, the amount required is often less while wearing the VR glasses. HypnoVR president Denis Graff, a medical anaesthetist and hypnotherapist, said: “We are trying to fight against the over-consumption of drugs, and we are trying to treat pain with a non-medicinal method in order to reduce the consumption of potentially dangerous drugs that can have severe side-effects.” *Image by Florian Pircher from Pixabay
Liver cancer patients in France are benefiting from world-leading robot technology that is helping physicians treat and operate on them. The only two of their kind, the two robots, developed by Montpellier-based medical device company Quantum Surgical, assist oncologists in the delivery of a treatment known as “elimination by microwaves”. Prior to the addition of the robots, physicians needed to guide a tiny needle into a liver cancer patient’s tumor so that microwaves could be passed into it. Now, the robots carry out this part using 3D images with pinpoint accuracy. The robots are being used as part of a clinical trial at Montpellier Hospital that will test the technology on 20 patients. Currently, it is only being used on liver cancer patients, but the technology has been used target cancerous tumours in animals’ lungs and kidneys. Professor Thierry de Baère, head of therapeutic imaging at the Institut Gustave Roussy in Villejuif, one of Europe’s leading cancer centres and one of two in France where the robot is currently used, said: “The robot can put a small needle in exactly the right place, from the right direction and at the right depth.” Prof de Baère has performed five operations using the technology and all the patients were discharged the next day. *Image courtesy of Quantum Surgical
Last year, makeshift terraces sprang up on many cafes across Paris, allowing COVID-wary patrons to be served outdoors. Now, city hall has announced these ‘Covid terraces’ will become a permanent fixture in the French capital this summer. In response to the impact of the pandemic on beleaguered restaurant and café owners who were no longer allowed to serve indoors, the city of Paris turned over thousands of parking spaces to enable establishments to continue serving drinks and food outdoors. Many establishment owners invested in high-quality structures in the spaces, which are still usable today. Terraces will have to remain without closed walls and plants and other greenery will be encouraged. "Roofs, tarps, reception tents, wooden pallets and advertising will be prohibited," the deputy mayor in charge of commerce, Olivia Polski, told AFP. There will also be a requirement for them to shut down by 10:00pm, so that local residents won’t be disturbed by any noise. The city will hold an annual contest for the most attractive designs, a move clearly aimed at encouraging aesthetically pleasing structures. Outdoor seating can also be extended on adjacent squares and sidewalks, and also in front of neighbouring businesses, providing they give approval. No heating or music systems will be allowed, and Polski said the city would step up deployments of specially developed "Meduse" microphones for pinpointing the sources of noise pollution across the city. Outdoor drinking and dining resumed across France last month as France emerged from its third wave of coronavirus cases, a huge relief for restaurants and bars closed since last October. On Wednesday, restaurants and cafés will be allowed to start serving indoors and the nationwide curfew will be pushed back to 11:00 pm, which is expected to further swell the summer sidewalk crowds. *Image: Lucas BARIOULET AFP/File
Prior to the Covid-10 pandemic, medical tourism was one of the fastest-growing industries in the world. Indeed, according to Grand View Research, the global medical tourism market size was valued at US$44.8 billion in 2019, with compound annual growth of 21.1% expected between 2020 and 2027. However, the global SARS-CoV-2 outbreak has significantly impacted travel abroad. Luckily, we are seeing signs that things are slowly returning to normal. [Related reading: France to offer free Covid-19 tests to tourists this summer] Now, something that has come into its own during the coronavirus pandemic is telehealth. In fact, data shows usage of telehealth services has increased by more than 2,000% since 2019. But what’s going to happen to telehealth services once “normal” travel resumes? We believe they’ll still play a pivotal role, particularly when it comes to complementing medical tourism. With telehealth, patients can have consultations with specialists on the other side of the world, negating the need to travel in the first instance. If the patient and clinician agree that travel for surgery or other healthcare is necessary, telehealth can continue to afford benefits, including: - Improve the quality and efficiency of customer service by helping to coordinate care between providers in the patient’s home country and the medical tourism destination - Enhance pre-operative and post-operative care - Optimize patient and family member travel. If you’d like to find out more about our telehealth services and/or how we can help you get any medical treatment you need in France, get in touch today. *Image courtesy of mohamed Hassan from Pixabay
While many European countries insist upon travelers presenting a negative Covid-19 test before they enter, France is looking to greet tourists more openly this summer, providing foreigners with the option to have a free PCR test when they arrive in the country. Speaking during an interview with Europe 1 news on Sunday, Secretary of State for European Affairs, Clement Beaune, said France is currently the only European country providing the option of free PCR tests to its citizens. He added that this facility will now be extended to foreign tourists arriving for vacation. Beaune said the move was designed to boost tourism in France and help the country economically. “We need, we want, in good sanitary conditions, to remain the leading European and world tourist destination,” he told BFMTV, another news channel. Covid-19 PCR tests currently cost anywhere from €50-€300 in Spain, UK, Germany, and Sweden. However, the European Parliament has called for countries to provide such tests for free, or at least make them more affordable. Beaune added that the planned digital health pass, which will include travelers’ vaccination details, is being eyed as a “tool for reopening” tourism. [Related reading: France is first EU member state to start testing digital COVID-19 travel certificate] *Image courtesy of mohamed Hassan from Pixabay
Parisian catwalks will reopen from July as the French government looks to wind down Covid-19 restrictions, paving the way for live fashions show to resume, the country's fashion industry body announced on Tuesday (May 11). The annual Haute Couture Week — which sees a select club of designers display one-of-a-kind, handmade outfits — will take place from July 5 to July 8 and fashion houses will be allowed to organise live shows and presentations, according to a statement from the French fashion industry body Federation De La Haute Couture Et De La Mode Depending on how the pandemic progresses, physical fashion shows with live guests would be allowed, in line with government guidance on public events. No major live fashion shows have been held in Paris since September 2020. Back then, some brands, including Dior and Chanel, organised a few shows with live audiences, but with a strictly limited number of guests. In the past months, fashion brands have presented their new lines in online-only shows and have experimented with other ways to showcase their designs such as short films and one-on-one presentations. The federation said its Haute Couture online platform https://hautecouture.fhcm.paris/fr would remain available for digital-only shows going forward and would also retransmit the physical shows. Prior to the Covid-19 pandemic, Paris’ multiple fashion weeks generated some 1.2 billion euros for the local economy every year, the federation grouping couture houses estimates. *Image courtesy of Pexels from Pixabay
Telemedicine will save the healthcare industry a staggering $21 billion in costs by 2025, new research suggests. This represents an increase of over 80% in the next four years, rising from $11 billion in 2021. According to the study by Juniper Research, teleconsultations, a service that enables patients and physicians to interact remotely with patients, will play a key role in enabling these significant savings. However, Juniper cautioned that such savings would be restricted to developed countries where people have access to required devices and suitable Internet connectivity. Indeed, Juniper predicts that North America and Europe will realise over 80% of savings by 2025. The Jupiter report also reveals how telemedicine usage has soared as a result of the coronavirus pandemic, with remote consultations rising from over 280 million in 2019, to 348 million in 2020. By taking advantage of telehealth solutions, doctor’s offices have been able to significantly reduce the number of face-to-face appointments they’ve needed to accommodate, cutting the risk of waiting room Covid-19 infections. However, the report did warn that the significant investment required and obligation to abide by data protection laws, such as the US’s Health Insurance Portability and Accountability Act (HIPAA), could discourage telemedicine adoption among smaller healthcare providers. “Any deregulation must ensure that patient confidentiality is not undermined,” said research author Adam Wears. “Additionally, we recommend that innovative and emerging teleconsultation services are integrated into existing healthcare technologies, such as electronic health records, to maximise their benefits to healthcare providers.” Jupiter Research’s report, Telemedicine: Emerging Technologies, Regional Readiness & Market Forecasts 2021‑2025, is available here: https://www.juniperresearch.com/researchstore/key-vertical-markets/telemedicine-research-report *Image by Tumisu from Pixabay
France’s third Covid-19 lockdown is easing. Children have returned to school across the country and a domestic travel ban has been lifted. Citizens can now travel anywhere in France, which is a huge improvement over the previous restriction that prevented people from going more than 10km (six miles) from their homes. French citizens also no longer need to carry a form giving a valid reason for travelling. However, a night-time curfew remains in force in the country, with restrictions in place from 19:00 to 06:00 nationwide France’s third lockdown, lighter than the previous two, was implemented back in March. Under the French government's plan, more easing will begin on 19 May, when the nationwide curfew will be pushed back to 21:00, cafes and restaurants will be allowed to welcome outdoor diners, and spectators will be allowed to return to sports venues. Along with indoor eating places, France will keep non-essential businesses, shopping centres and leisure facilities closed. The lockdown easing comes as France continues to register around 25,000 new coronavirus infections each day. Fortunately, the number of patients in intensive care units has dropped below 5,600. *Image by Phil Riley from Pixabay
We recently wrote about how France is the first EU member state to start testing digital COVID-19 travel certificate. Now, the UK has announced that it will use its NHS health app as a vaccine passport going forward. Part of UK Prime Minister Boris Johnson’s roadmap for enabling international travel, the vaccine passport will allow vaccinated Britons to enjoy quarantine-free travel to certain countries this summer. The UK Government has set out plans for a "traffic light" system to be used to categorise different destinations. Speaking to Sky News on Wednesday, UK Transport Secretary, Grant Shapps, said that more details about the vaccine passport will be revealed "in the next couple of weeks", including which countries will be included on the so-called "green list". Britons will be able to travel to these destinations without having to quarantine on their return. However, travellers will still be expected to have a Covid-19 test both when departing the UK and upon their return. Mr Shapps also confirmed that the UK NHS smartphone app will be used to store people’s vaccine information, effectively making it a vaccine passport. Speaking about the possibility of vaccine passports being around for the long term, Christopher Dye, a professor of epidemiology at the University of Oxford, told the UK science and technology select committee: “One reason is that Covid is not going to go away; it is going to be endemic around the world, it is going to keep resurfacing, and I think that, just as we’ve had yellow fever passports for years and years and years, we’re going to have Covid passports too”. *Image courtesy of Jan Vašek from Pixabay
France has become the first European country to begin testing a digital Covid-19 travel certificate as part of a Europe-wide scheme which Brussels hopes will allow more freedom of travel within the bloc by the summer. The testing will be conducted through France’s TousAntiCovid app, part of the country’s contact tracing programme, which has been upgraded to allow it to store negative Covid-19 test results on travellers’ mobile phones. The app is being trialled on flights to Corsica and overseas départements from this week. According to a French official, at first, the certificates will only be used for travel, but they “could eventually be adopted for public events such as concerts, festivals and trade fairs,” although not for bars and restaurants. The app has so far been downloaded by nearly 15 million French citizens. The French trial will form one part of a “reinforced, consolidated and standardised” Europe-wide system, the minister for digital transition, Cédric O, said. Talks are already underway with several countries and airlines to ensure early recognition. The European commissioner for justice, Didier Reynders, said last week he expected the EU’s “digital green certificate” to be operational by 21st June. The certificate is an urgent priority for southern European member states whose economies have been hit hard by the coronavirus pandemic. *Image by Pexels from Pixabay
French President Emanuel Macron has revealed that France could allow vaccinated touriusts, including Americans and Britons, to enter the country in May. Macron said France is in its last stage of finalising the progressive lifting of travel restrictions for vaccinated travellers and people who have tested negative for COVID-19. Restrictions will reportedly be lifted for European Union and third-country citizens, according to SchengenVisaInfo.com. The president said that French ministers are finalising the details for safe restriction-free travel and developing a testing and vaccination certificate to facilitate travel among EU countries. “We will progressively lift the restrictions of the beginning of May, which means that we will organise in the summertime with our professionals in France for French European citizens, but as well for American citizens. So we are working hard to propose a very concrete solution, especially for U.S. citizens who are vaccinated, so with a special pass, I would say,” Macron said. With the establishment of a so-called “vaccine passport”, Macron pointed out that the country would be able to control the virus and maximise the vaccination rates, which would allow restrictions to be lifted progressively. Macron also revealed that he had spoken with the White House about potential plans for lifting some travel restrictions between France and the US, though talks were still in their early stages. *Image courtesy of Phil Riley from Pixabay
As we highlighted in a previous blog post, telehealth/telemedicine services have come into their own during the Covid-19 pandemic, allowing patients to connect with their clinicians in a way that’s fast, convenient and safe. However, remote consultations often have their limitations, including how to perform diagnostic tests and take medical measurements. But now researchers from the University of Washington have devised a way to measure patients' pulse and breathing rates via a smartphone's camera. The researchers say the advancement will make telehealth more accurate and useful. According to UW News, the system, called MetaPhys, can detect a patient’s pulse or respiration rate using in real-time using video of their face. "Machine learning is pretty good at classifying images. If you give it a series of photos of cats and then tell it to find cats in other images, it can do it," Xin Liu, the study's lead author and a student in the Paul G. Allen School of Computer Science & Engineering doctoral student, told UW News. "But for machine learning to be helpful in remote health sensing, we need a system that can identify the region of interest in a video that holds the strongest source of physiological information — pulse, for example — and then measure that over time." The team's original iteration of MetaPhys was presented last December at the Neural Information Processing Systems conference. However, the first iteration had some pitfalls, most notably that it struggled with certain lights, backgrounds and skin colors. The second version, the researchers say, improves upon the first and overcomes these limitations. *Image courtesy of tookapic from Pixabay
Prior to the Covid-19 pandemic, telehealth/telemedicine services were more of a convenience than a necessity for most patients. They offered (and still do offer) a way for a patient to consult with their clinician without having to make a trip to the doctor’s office. But it was when the Covid-19 pandemic struck that telehealth really came into its own, with more patients than ever taking advantage of such services to receive non-emergency healthcare from the safety of their own homes. Now, new research from Sykes reveals that most consumers – having experienced telehealth services during the pandemic -- want them to remain post-Covid. According to the Sykes survey, which polled 2,000 Americans in March on how their opinions on virtual care have changed within the past year, more than 61% had undergone a telehealth visit come March this year. In comparison, less than 20% had utilized telehealth by March 2020. Furthermore, in March 2020, around 65% of Americans felt hesitant or doubtful about the quality of telehealth services, while 56% did not believe they could afford the same level of care compared to in-person appointments. However, now, almost 88% want to continue using telehealth for non-urgent consultations after the COVID-19 pandemic has ended. Moreover, almost 80% agree it's possible to receive quality care via telehealth services. *Image by Tumisu from Pixabay
Musicians in Montauban, a commune in the Tarn-et-Garonne department in the Occitanie region in southern France, performed a public concert last weekend for the first time in months. But don’t worry, no Covid-19 restrictions were broken because the musicians performed from open windows in the centre of the town. The Fenêtres musicales (Musical windows) event took place on Sunday, March 21. Musicians across the town opened windows in central buildings, and played their instruments for passing members of the public. Hugo Schmitt, saxophonist at the Orchestre de la Cité at Ingres, told FranceInfo: “After a year without any concerts, it’s a real relief. To be able to play in the centre of Montauban, in beautiful apartments next to open windows, especially during this period, which has been hard for us as artists, it’s really a gift.” Around 20 musicians played via open windows for the event, with the “concert” lasting around 90 minutes. A small crowd also gathered to listen to three singers and a pianist lay a rendition of Mozart’s Nocturnes. One of the singers, Eugenie Berrocq, said: “Because we can’t go to theatres, and we can’t do this in a more conventional or traditional way, we have to reinvent ourselves. There are many artists who have done this, and I think it’s a very good idea to do it in this way.” One Montauban resident said: “We’ve been without culture for a year now, it’s starting to get a bit long. So this kind of initiative is great.” Another said: “It’s nice, it does you good to watch people playing. We’ve missed it a bit.” *Image courtesy of FranceInfo
Germany, France, Italy and Spain have joined the list of countries to suspend use of AstraZeneca’s COVID-19 vaccine. The countries took the decision after reports have arisen of dangerous blood clots in some recipients. Meanwhile, AstraZeneca and European regulators have said there is no evidence the vaccine is to blame. The AstraZeneca shot is one of three vaccines currently in use in Europe. Nevertheless, the blood clot concerns and subsequent cessation of its use represents another setback for the EU’s vaccination drive – which has already been slow off the mark compared to similar campaigns in the United Kingdom and the United States. The EU’s drug regulatory agency has called a meeting for this week to review experts’ findings on the AstraZeneca vaccine and decide how to proceed. All this comes as much of Europe tightens restrictions on schools and businesses as Covid-19 cases surge. In Germany, the decision to halt the use of the Astrazeneca vaccine was taken following advice from the country’s vaccine regulator, the Paul Ehrlich Institute. It called for further investigation after blood clots were found in the brains of seven people who had been vaccinated. In response to the situation, Astrazeneca published a press release offering ‘reassurance on the safety of its COVID-19 vaccine based on clear scientific evidence’.
France is gearing up for a possible easing of COVID-19 lockdown restrictions from mid-April, as vaccines, to date, are proving effective at lowering infection rates. French government spokesman Gabriel Attal said on Wednesday that while the nation is still facing hard times, “For the first time in months, the return to more normal living conditions is in sight.” Attal said vaccinated groups (mainly the elderly) are witnessing falling infection rates, which, he said, is a sign that the country’s vaccination program is working and should be sped up. "It is neither a distant nor uncertain horizon - it is an horizon that is getting closer and closer. We hope maybe from mid-April, and we are preparing for it. "The president (Emmanuel Macron) asked us to submit proposals that could allow for a cautious re-opening of the country soon,” he said. Attal added that the goal of vaccinating the most fragile was to reduce hospitalizations and safeguard the nation’s health care system, which is key to easing restrictions. Earlier this week, Health Minister Olivier Veran said France will retain its current measures aimed at limiting the spread of COVID-19, including a nighttime curfew, as a bare minimum for the next four to six weeks. Other measures now in force include the closure of bars, restaurants, museums, sports and music venues. COVID-19 is the disease caused by the coronavirus.
People in France aged over 65 with existing health problems will be allowed to be given the AstraZeneca COVID-19 vaccine, after the French Government reversed its policy. When the AstraZeneca vaccine was approved for use by European Union regulators, the French Government said it should only be given to eligible people under 65 because data from trials in older age groups was limited. The AstraZeneca vaccine will now be offered to people up to the age of 74. However, the shot has been hit by a slow rollout and a lack of trust. French Health Minister Olivier Veran said Monday: "Anybody aged 50 or over who is affected by co-morbidities can get the AstraZeneca vaccine, including those between 65 and 74." The announcement has the potential to affect more than two million people. British health authorities released new data on Monday that showed the AstraZeneca vaccine reduced hospitalization from COVID-19 by more than 80%. The vaccine is widely used in the UK but has missed delivery targets in the EU. People aged 75 and over would continue to get the Pfizer and Moderna vaccines only, Veran said. Meanwhile, Germany still hasn’t cleared the AstraZeneca vaccine for over 65s. This has led to fewer people stepping up for the shot and several doses being wasted. Image courtesy of Marco Verch on Flickr, licensed under the Creative Commons Attribution 2.0 Generic (CC BY 2.0)
The COVID-19 pandemic has caused telehealth to become a bigger economic development concern among local areas. That’s one of the key findings of new research by broadband industry analyst Craig Settles. According to Settles’ Broadband, Local Economies, & the Age of Covid survey -- which polled 200 professionals from economic development departments within local and state governments and economic development agencies across the United States – 40% of respondents indicated that telehealth can have a “measurable impact” on their local economy in terms of attracting medical professionals and reducing unnecessary ER visits. When the same survey was conducted two years ago (in 2019), only about 25% of respondents said the same about telehealth’s potential impact on the medical workforce and ER visits. Moreover, more respondents this year said telehealth can help more mental health services remain local, as well as keep senior citizens living at home longer. Settles says these findings suggest there is money to be made and saved by boosting telehealth capabilities. Specifically, he sees a lot of potential value in local telehealth radiology programs, citing the $1.8 million saved over 10 years by a radiology practice in Chattanooga, Tennessee. “There are serious dollars and cents to be had if you can do this locally, because people don’t have to go all the way to China to get their X-rays, all the various MRIs and so forth,” Settles said. “The forward-thinking communities, especially if they’re a rural area, I would look at starting a radiology practice because there’s money to be made there locally. Obviously, you can’t do this without broadband, but if you’re one of these cities building the network, that should be a main consideration for revenue.”
A single dose of Pfizer/BioNTech’s Covid-19 vaccine reduces a person’s risk of infection by 72%, a new study has revealed. According to Public Health England (PHE), the first dose of the Pfizer/BioNTech Covid-19 vaccine "provides high levels of protection against infection and symptomatic disease.” PHE's Siren Study, which involved healthcare workers aged under 65, found that one dose of the Pfizer/BioNTech Covid-19 vaccine reduced the risk of infection by 72% after three weeks. Two doses of the vaccine reduced the risk of infection by 85%. This high level of protection also includes the B.1.1.7 coronavirus variant first identified in the UK in December. For the study, health workers were tested for Covid-19 infection every two weeks using PCR tests and twice a week with lateral flow tests. As Dr. Susan Hopkins, strategic response director at PHE, explained, "there was a lot of asymptomatic testing.” "Overall we are seeing a really strong effect to reducing any infection: asymptomatic and symptomatic," Hopkins said during a press conference held by the UK's Science Media Centre on Monday. Promising early data has also shown that people who are vaccinated and subsequently catch Covid-19 are far less likely to die of, or be hospitalized with, the virus. For example, people over the age of 80 who were infected after being vaccinated were 41% less likely to be hospitalized with the virus and 57% less likely to die of it.
The World Health Organization (WHO) yesterday gave two versions of the AstraZeneca/Oxford COVID-19 vaccine the green light to be used for emergency use, listing them on its Emergency Use Listing (EUL), paving the way for them to be rolled out globally through COVAX. The vaccines are produced by AstraZeneca-SKBio (Republic of Korea) and the Serum Institute of India. WHO’s EUL assesses the quality, safety and efficacy of COVID-19 vaccines and is a prerequisite for COVAX Facility vaccine supply. It also allows countries to expedite their own regulatory approval to import and administer COVID-19 vaccines. “Countries with no access to vaccines to date will finally be able to start vaccinating their health workers and populations at risk, contributing to the COVAX Facility’s goal of equitable vaccine distribution,” said Dr Mariângela Simão, WHO Assistant-Director General for Access to Medicines and Health Products. ‘But we must keep up the pressure to meet the needs of priority populations everywhere and facilitate global access. To do that, we need two things – a scale-up of manufacturing capacity, and developers’ early submission of their vaccines for WHO review.” Pfizer/BioNTech’s vaccine was listed for emergency use by WHO on 31 December 2020.
Europe's oldest living person has survived COVID-19 after testing positive just weeks before her 117th birthday. Sister André, a French nun who was born in 1904, tested positive in the retirement home where she lives in Toulon, southern France, on January 16, according to the home’s communications director, David Tavella. André, who was born Lucille Randon, showed no symptoms from the virus and didn’t even know she was infected until she received her positive test. Despite no visitors being allowed because of strict COVID protocols, André is preparing to celebrate her 117th birthday today, Thursday 11th February. She will reportedly receive video messages from her family and the local mayor, as well as taking part in a video Mass, Tavella said. André's birthday meal will feature her favorites: foie gras, baked Alaska and a glass of red wine, Tavella added. Remarkably, André has lived through two world wars, as well as the 1918 Spanish Flu pandemic that infected around 500 million people. While Andre is the oldest living person in France today, she’s not the oldest in the world. That crown is held by Kane Tanaka, a Japanese woman who was born in 1903, according to the Gerontology Research Group (GRG). * Image credit Gérard Julien/AFP/Getty Images
Against expectations, France has resisted imposing a nationwide lockdown, choosing to introduce new Covid-19 border restrictions instead. Under the new restrictions, all non-essential travel from outside the EU has been banned and testing requirements for travellers from within the EU have been tightened. French Prime Minister Jean Castex said France's night curfew would also be more tightly enforced and large shopping centres would close. It had been expected that French President Emmanuel Macron would impose a third national lockdown to contain Covid-19. However, the French premiere opted to tighten existing restrictions on travel and shopping instead. The move sees France following a different path than its two biggest neighbours Britain and Germany, at a time when the more contagious UK variant of the disease is spreading rapidly across Europe. [Related reading: Moderna says its vaccine will work against new COVID variants] "Everything suggests that a new wave could occur because of the variant, but perhaps we can avoid it thanks to the measures that we decided early and that the French people are respecting," Health Minister Olivier Veran told the Journal du Dimanche (JDD) newspaper on Sunday. Despite the news of tighter border restrictions, France Surgery’s proprietary telehealth platforms remain open and accessible to all of our international clients, one of the main benefits of remote healthcare.
With reports emerging that several different COVID variants are now circulating around the world, Moderna has released a statement saying it believes its vaccine protects against at least two of the new strains. Moderna Inc said on Monday it believes its COVID-19 vaccine protects against both new variants found in Britain and South Africa. However, the American pharmaceutical and biotechnology company also said it will test a separate booster shot aimed at the South African variant after concluding the antibody response could be diminished. The company said in a press release that it found no reduction in the antibody response against the variant found in Britain. Against the South African variant, Moderna said it found a reduced response but still believed its two-dose regimen would provide protection. The emergence of new COVID variants in Britain, South Africa and Brazil has created some concern that mutations in the virus may make vaccines less effective. Moderna’s announcement will serve to alleviate some of that concern, but the proof will be in the infection numbers going forward. Moderna shares rose nearly 10% off the back of the news during Monday trading. Moderna said it plans to publish data from its tests against the variants on the website bioRxiv.
Newsweek, in collaboration with Statista Inc., has compiled a league table of the world’s best specialized hospitals 2021, and France has no less than 26 Cancer Centers (CLCCs) in the top 200. Topping the list of French oncology hospitals is Institut Gustave Roussy in Villejuif, which ranked fifth in the overall oncology list. Two more French cancer centers – Institut Curie and Hôpital Universitaire Pitié Salpêtrière – were also in the top 50, ranking 12th and 31st respectively. All in all, 26 French cancer hospitals were included in the top 200 global oncology list, highlighting just how renowned these establishments are on the international medical stage. Speaking about the rankings, Jean-Yves Blay, President of Unicancer – the National Federation of French Cancer Centres – said: “We are proud to see that more than half of CLCCs are ranked among the best cancer hospitals in the world. The model of care for cancer patients within the CLCCs is unique and this international recognition underscores the strength and excellence of our network, supported by common values and commitments, at the service of the patient. It also testifies to our constant quest for excellence in healthcare, research and higher education.” For the rankings, Newsweek and Statista surveyed more than 40,000 medical experts from over 20 countries. A global board of experts was then asked to review and rank the hospitals outlined in the survey. You can check out the full Newsweek oncology ranking here.
A Singaporean woman who was infected with Covid-19 while pregnant has given birth to a baby which has antibodies against the disease. The mother, Celine Ng-Chan, became mildly ill after contracting Covid-19 and spent two-and-a-half weeks in hospital as a result. Ng-Chan gave birth last month and her baby was found not to have Covid-19. However, the fact it had antibodies offers new clues as to whether the disease can be passed from mother to child in utero. Speaking to the Straits Times newspaper, Ng-Chan said: “My doctor suspects I have transferred my COVID-19 antibodies to him during my pregnancy.” Ng-Chan and her baby’s experience has prompted doctors in Singapore’s public hospitals to investigate further the impact of Covid-19 on unborn babies. This will add to research already being conducted internationally on whether the infection can be transferred during pregnancy, how babies develop antibodies in the womb and whether they offer an effective shield against the virus. One of the hospitals involved in the studies is KK Women’s and Children’s Hospital. Tan Hak Koon, chairman of the Obstetrics and Gynaecology division at KK, said: "It is still unknown whether the presence of these antibodies in a newborn baby confers a degree of protection against Covid-19 infection, much less the duration of protection."
It is estimated that a child is born every 3 minutes with a cleft lip, cleft palate or both worldwide — about one in 500-750 births. Usually, with surgery, a child born with a cleft can have a new, beautiful smile and live a normal life. However, the ongoing Covid-19 pandemic has meant that affected babies are having even greater difficulty in getting their much-needed cleft treatment. Fortunately, cleft charities are continuing their work by taking advantage of telehealth solutions. One such charity is Smile Train, whose Philippine arm has continued providing ongoing comprehensive cleft care including nutrition, speech therapy and psychological support to patients, despite temporarily postponing surgeries. “This year was a different year because of the Covid pandemic. The last three or four months we saw a drop in the number of cases in many hospital nationwide. Some stopped doing operations. But Smile Train is not just about surgery. What we strive to do is to be able to provide cleft comprehensive care to those who need it whether be it counseling, guidance in terms of how do you breastfeed baby with a cleft or after surgery, what does the child still need, among others,” said Kimmy Coseteng-Flaviano, Country Director of Smile Train Philippines, during a virtual media conference. Flaviano said the charity is also providing psychosocial support to older patients via telehealth, to help boost their self-confidence. Since parents of cleft babies aren’t able to visit clinics resulting to unanswered questions, Smile Train is trying to support them through virtual consultations with their partner surgeons or doctors, or through Facebook Live discussions.
A researcher from the University of Southern California (USC) Medical Center in Los Angeles says telemedicine had a positive impact on inner city children with asthma at the start of the Covid-19 pandemic. According to Kenny Kwong, MD, making the switch to telemedicine for routine asthma visits early on in the pandemic resulted in positive disease control and an increase in appointment "show rates" among Los Angeles inner city children. Prior to taking advantage of telemedicine, in-person appointment show rates between March and June 2019 averaged 70%-80%. After the switch to telemedicine, this increased to 90%-95% between March and June 2020. Furthermore, delivering routine asthma care via telemedicine did not appear to negatively impact asthma control among the children in the study, Wong said in a presentation at the American College of Allergy, Asthma & Immunology virtual meeting. There was also a notable increase in the amount of time healthcare providers spent with patients after switching to telemedicine, with appointments conducted over the telephone lasting as much as 62% longer than pre-pandemic in-person visits. “This system has worked very well. We have been able to treat many asthmatic children until the debacle of COVID-19. All our face-to-face visits on the mobile asthma units came to a grinding halt, and we had to switch almost overnight to telephone visits,” Wong said.
Telehealth is probably not the first thing you think of when talking about ways of assessing possible stroke patients in an emergency. But Norther Ireland has just approved exactly such a system, highlighting the traction that telehealth solutions are garnering today. The solution, provided by Health Services Limited (HSL), enables clinicians and patients to have video consultations, with the ultimate goal being to make a diagnosis. Patients still need to visit an A&E department, but when they do the emergency clinicians who receive them can use the telehealth solution to get expert treatment advice remotely from stroke consultants. The solution can be used on tablets, smartphones and laptops, making it different to other virtual stroke assessment tools in the market that rely on external systems to function, the company claims. It has everything built-in that a stroke consultant needs to make an initial diagnosis of the stroke patient. The app also has the functionality to save the patient’s results in their electronic care record. [Related reading: The benefits of electronic health records] Perhaps the biggest benefit of the telehealth solution is that it enables stroke consultants to assess a patient’s condition as soon as possible and relay timely, potentially life-saving advice to their emergency room counterparts. The stroke assessment telehealth solution is already in place in hospitals across Northern Ireland the United Kingdom.
Since the onset of the Covid-19 pandemic, the number of patients utilizing telehealth solutions has increased significantly. But with telehealth set to remain a mainstay of healthcare going forward, it begs the questions of what are the pros and cons of telehealth? We’ve listed some of each below to help you make an informed decision. Advantages of telehealth for patients: - Patients can typically get an appointment sooner - Appointments are carried out in the safety of a patient’s home or workplace — saving time and money on gas and parking - Telehealth allows elderly patients and those with reduced mobility, as well as people in rural locations, continued access healthcare services - Telehealth services are designed to be easy to adopt - Recent Medicare rule changes in the United States mean that people in more states are covered and can take advantage of telehealth services as part of their health plans - Telehealth services can often be used via a smartphone - A great way to satisfy post-surgical follow-ups Advantages of telehealth for healthcare providers: - More free time to help the neediest patients - Less overcrowding in doctor’s practices - Easier to implement social distancing guidelines Disadvantages of telehealth: - Not suitable for emergency situations (although tele-ICUs are a thing) - Not suitable for when a clinician needs to physically interact with a patient - Unsuitable for routine vaccinations - Not as intimate as a traditional face-to-face appointment If you’d like to find out more about the telehealth services provided by France Surgery, please get in touch.
We’ve written before about how telehealth has come into its own during the Covid-19 pandemic. Adoption of telehealth has allowed patients with less serious ailments to remain at home and seek advice remotely, freeing up clinicians’ precious time to focus on individuals with more pressing healthcare needs. Now, new research shows that when utilized in an ER setting, telehealth solutions can yield positive results for both patients and providers. According to the research published in the INFORMS journal Information Systems Research, which looked at emergency room visits in New York from 2010 to 2014, increasing wider use of telehealth in the emergency room can reduce both wait times and patient length of stay. When it came to patient length of stay, telehealth had a positive impact because it allowed for more flexible resource allocation, particularly when there is an ER demand surge and/or supply shortage. Furthermore, adoption of telehealth in ERs also reduces patient wait time, a reality that in turn reduces length of stay. This is a particularly important factor because of the common and nagging problem of overcrowding in ERs. With social distancing guidelines still firmly in place, reducing overcrowding in emergency rooms needs to be a top priority for hospitals.
Cleveland Clinic has unveiled its top 10 medical innovations for 2021, and both telemedicine initiatives and app-connected health trackers feature. In fact, four medtech developments made the Cleveland Clinic list this year, underlining the importance of technology in healthcare. All of them were chosen in the belief they will be widely adopted in the coming year and have a significant clinical impact. Announced in conjunction with its annual Medical Innovation Summit, which is now in its 18th year, Cleveland Clinic’s top 10 innovations for this year were selected by a committee of subject matter experts at the academic medical center. This year, smartphone app-connected pacemakers were named the top medtech innovation because of their ability to better connect patients with their cardiac treatment, affording greater insights into the health data they produce. Bubble CPAP, a non-invasive ventilation strategy for premature babies, is the next medtech innovation on the Cleveland list. Bubble CPAP minimizes physical trauma and stimulates lung growth when administered over a prolonged period. Third on the list of medtech innovations is telemedicine, specifically increased access to these pivotal services through the removal of barriers. The fourth and final medtech innovation on the list is vacuum-induced uterine tamponade, a minimally invasive way for clinicians to stop postpartum hemorrhage (excessive bleeding after having a baby), which affects around one to five percent of women who give birth. The vacuum-induced device uses negative pressure created inside the uterus to collapse the bleeding cavity causing the muscle to close off the vessels. It’s a low-tech solution that could be taken advantage of in developing countries with low resource availability. [Related reading: What is telehealth?]
In a previous blog — What is telehealth?— we introduced you to telehealth and explained how it has revolutionized healthcare across the world, especially in the face of the COVID-19 pandemic. But while telehealth has proven itself as a very worthy asset for enabling rural communities and those who cannot easily travel to access healthcare, what about when a patient is in a more critical condition and requires intensive care? Well, believe it or not, there are actually telehealth-ICU solutions out there for this very purpose. In a nutshell, a tele-ICU enables remote clinicians to interact with bedside staff to consult on a patient’s care. One centralized care team can manage a large number of ICU locations across many different locations to exchange health information in real time. Using a host of technologies, including A/V conferencing and real-time data streams of patient information from multiple sensors and interfaces, a clinician working from a care center hundreds of miles away can effectively and rapidly care for a patient no matter what time of day or night it is. As highlighted during the COVID-19 pandemic, anything that minimizes infection risk and the need for PPE, while still allowing clinicians to care for patients is extremely advantageous. While a tele-ICU is a supplement, not a replacement, to the on-site care team, when remote and bedside teams are able to collaborate seamlessly, the partnership elevates bot care and outcomes.
With the number of confirmed COVID-19 cases worldwide now at more than 25 million, any news involving potential vaccines is important, which is why a recent announcement from AstraZeneca Plc is exciting. The British multinational pharmaceutical and biopharmaceutical company, which has its headquarters in Cambridge, England, says it has begun to enroll 30,000 participants aged above 18 in the United States for a large-scale human trial of its COVID-19 vaccine candidate, AZD1222. The US trial will evaluate whether the vaccine can prevent COVID-19 infection or keep the illness from becoming severe, the National Institutes of Health said in a statement. It also will assess if the vaccine can reduce incidence of emergency department visits due to COVID-19. AstraZeneca says the study is being funded by the US Government and that participants will either receive two doses of either AZD1222 or a saline control (a placebo), four weeks apart. The AstraZeneca shot, which has been developed by researchers from the University of Oxford, is one of the farthest along of numerous COVID-19 vaccines in development. As well as the US trial, a final-stage test of the vaccine is underway in the United Kingdom. Preliminary results from this test could be yielded as soon as next month. Other companies that have COVID-19 vaccines in phase 3 trials include Moderna Inc. and Pfizer Inc.